Modeling Test and Treatment Strategies for Presymptomatic Alzheimer Disease-Reference-Cited by-同舟云学术

Modeling Test and Treatment Strategies for Presymptomatic Alzheimer Disease

Published:2014-12-04 Issue:12 Volume:9 Page:e114339
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Burke James F.,Langa Kenneth M.,Hayward Rodney A.,Albin Roger L.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference30 articles.

1. Aspirin, statins, or both drugs for the primary prevention of coronary heart disease events in men: a cost–utility analysis;M Pignone;Ann Intern Med,2006

2. Monetary costs of dementia in the United States;MD Hurd;N Engl J Med,2013

3. Stroke risk profile: adjustment for antihypertensive medication. The Framingham Study;RB D’Agostino;Stroke,1994

4. World Health Organization, Alzheimers Disease International (n.d.) Dementia: a public health priority. Available: http://www.who.int/mental_health/publications/dementia_report_2012/en/.

5. Primary and subsequent coronary risk appraisal: new results from the Framingham study;RB D’Agostino;Am Heart J,2000

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of Population-Level Blood Pressure Treatment Strategies on Cardiovascular and Cognitive Outcomes;Circulation: Cardiovascular Quality and Outcomes;2024-06

2. Development and validation of the Michigan Chronic Disease Simulation Model (MICROSIM);PLOS ONE;2024-05-16

3. Lecanemab: Looking Before We Leap;Neurology;2023-07-21

4. Development and Validation of the Michigan Chronic Disease Simulation Model (MICROSIM);2022-03-23

5. c-Jun N-Terminal Kinase Inhibitors as Potential Leads for New Therapeutics for Alzheimer’s Diseases;International Journal of Molecular Sciences;2020-12-18